Home › Overweight › Massachusetts › New Bedford
Overweight clinical trials in New Bedford, MA
7 studies for Overweight are looking for participants at sites in and around New Bedford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Lucida Clinical Trials, New Bedford
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Lucida Clinical Trials, New Bedford
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Lucida Clinical Trials, New Bedford
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Btc of New Bedford, New Bedford
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, North Dartmouth · 2 mi away
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Lucida Clinical Trials, New Bedford
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Lucida Clinical Trials, New Bedford
Overweight trials in other cities
- San Antonio, TX33 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Miami, FL23 studies
- Las Vegas, NV23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in New Bedford
- Obesity7 studies
- Crohn's Disease6 studies
- COPD4 studies
- Type 2 Diabetes3 studies
- Ulcerative Colitis3 studies
- Alzheimer's Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.